By Femtech Insider Biotech, Career, News, Pharma, Uncategorized May 31, 2021 ShareTwitterFacebookPinterest-circled Dr. Stephen Palmer Joins the Celmatix Executive Team to Lead the Company’s Drug Discovery and Development Efforts in Ovarian Health as Chief Scientific Officer
By Femtech Insider Biotech, Career, Pharma, Women's Health May 25, 2021 ShareTwitterFacebookPinterest-circled Biovaxys Adds Charles J. Dunton, MD as Scientific Advisor to Support the Company’s Ovarian Cancer Vaccine Clinical Program and Papilocare Marketing
By Femtech Insider Biotech, News, Pelvic Health, Pharma, Women's Health May 13, 2021 ShareTwitterFacebookPinterest-circled Evofem Receives Fast Track Designation for EVO100 for Prevention of Gonorrhea in Women
By Femtech Insider Biotech, News, Uncategorized May 4, 2021 ShareTwitterFacebookPinterest-circled Merck Hosts Organon Investor Day Introducing the New Company’s Vision and Focus on Women’s Health
By Femtech Insider Biotech, Investment, News, Pregnancy April 29, 2021 ShareTwitterFacebookPinterest-circled Pregnancy Company Sera Prognostics Completes a $100 Million Series E Financing to Expand Commercialization of its PreTRM Test
By Femtech Insider Biotech, News, Reproductive Health, Women's Health April 28, 2021 ShareTwitterFacebookPinterest-circled Contraception: Evofem Announces the Presentation of Two New Phexxi Data Sets at the 2021 American College of Obstetricians and Gynecologists Annual Meeting
By Femtech Insider Biotech, News, Oncology, Pelvic Health, Women's Health April 23, 2021 ShareTwitterFacebookPinterest-circled Roche Receives FDA Approval for the First Companion Diagnostic to Identify Endometrial Cancer Patients Eligible for Immunotherapy
By Femtech Insider Biotech, News, Reproductive Health April 19, 2021 ShareTwitterFacebookPinterest-circled Mayne Pharma’s Receives FDA Approval for NEXTSTELLIS, a New Oral Contraceptive Containing E4, the First New Estrogen Introduced in the U.S. in 50 Years
